Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari Thomas

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Lupus|December 6, 2021
Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic reviewCandido Muñoz Muñoz, Kawser Ahmed, Mari Thomas, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2026
Caplacizumab resistance in immune thrombotic thrombocytopenic purpura (iTTP) associated with VWF A1 domain missense variantMari Thomas, Imogen Buckle, Adela Constantinescu-Bercu, et al.
European Journal of Haematology|June 1, 2020
Immune thrombocytopenia in adults: A single-centre review of demographics, clinical features and treatment outcomesPhilippa Woolley, Rosalind Newton, Siobhan Mc Guckin, et al.
Blood Advances|May 19, 2020
High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS RegistryZara Sayar, Anna Weatherill, Stephen Keddie, et al.
Ejhaem|July 18, 2022
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpuraFerras Alwan, Chiara Vendramin, Ulrich Budde, et al.
Blood|January 31, 2023
Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab eraNithya Prasannan, Mari Thomas, Matthew Stubbs, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 6, 2021
Venous thromboembolism in women with ovarian cancer undergoing neoadjuvant chemotherapy prior to cytoreductive surgery: A retrospective studySamuel G Oxley, Yaa A Achampong, Nikola Sambandan, et al.
Thrombosis Research|March 12, 2022
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort studyZara Sayar, Carolyn Gates, Sotirios Bristogiannis, et al.
Blood Advances|May 4, 2022
Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpuraJin-Sup Shin, Maryam Owais Subhan, Geraldine Cambridge, et al.
Blood|March 19, 2024
Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpuraNithya Prasannan, Bertina Dragunaite, Maryam Subhan, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Lupus|December 6, 2021
Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic reviewCandido Muñoz Muñoz, Kawser Ahmed, Mari Thomas, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2026
Caplacizumab resistance in immune thrombotic thrombocytopenic purpura (iTTP) associated with VWF A1 domain missense variantMari Thomas, Imogen Buckle, Adela Constantinescu-Bercu, et al.
European Journal of Haematology|June 1, 2020
Immune thrombocytopenia in adults: A single-centre review of demographics, clinical features and treatment outcomesPhilippa Woolley, Rosalind Newton, Siobhan Mc Guckin, et al.
Blood Advances|May 19, 2020
High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS RegistryZara Sayar, Anna Weatherill, Stephen Keddie, et al.
Ejhaem|July 18, 2022
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpuraFerras Alwan, Chiara Vendramin, Ulrich Budde, et al.
Blood|January 31, 2023
Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab eraNithya Prasannan, Mari Thomas, Matthew Stubbs, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 6, 2021
Venous thromboembolism in women with ovarian cancer undergoing neoadjuvant chemotherapy prior to cytoreductive surgery: A retrospective studySamuel G Oxley, Yaa A Achampong, Nikola Sambandan, et al.
Thrombosis Research|March 12, 2022
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort studyZara Sayar, Carolyn Gates, Sotirios Bristogiannis, et al.
Blood Advances|May 4, 2022
Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpuraJin-Sup Shin, Maryam Owais Subhan, Geraldine Cambridge, et al.
Blood|March 19, 2024
Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpuraNithya Prasannan, Bertina Dragunaite, Maryam Subhan, et al.
Pageof 4